Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France

NCT07122557 is registered in ClinicalTrials.gov with Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba as lead sponsor.

NCT NCT07122557
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07122557 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France
Lead sponsor
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase
Observational
Overall status
Not yet recruiting
Start date
September 30, 2025
Completion date
December 31, 2025
Enrollment
320 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

bic/ftc/taf, hiv-1, low income population, public universal healthcare insurance coverage